It can be life-changing for patients when a promising new drug is approved for widespread use. But before a patient can start a new treatment that could improve their health or save their life, they often must go through a complicated process of verifying benefits, complying with prior authorization requirements, and considering financial implications before moving forward.
Lash Group, an AmerisourceBergen company, works with pharmaceutical (pharma) companies to streamline these key steps. The company provides ongoing patient support throughout their treatment journey under Lash Group’s umbrella of access, affordability, and adherence solutions. Lash Group leads with a high tech, high touch approach to patient support program design, automating as much as possible and augmenting with skilled and compassionate counselor support.
The administrative procedures can be particularly complex depending on a number of factors, including the therapy benefit profile. Following prescription, patients can enroll in support programs to help them overcome obstacles to starting and staying on the therapy. However, administrative steps to complete the enrollment process can be complex. To initiate patient support, providers and patients must fill out forms and submit paperwork, including providing patient consent and authorization for enrollment and disclosures. This all takes time.
For pharma companies that want to fast-track the patient journey digitally, Lash Group provides an online provider portal that streamlines complex paperwork. As a part of the Adobe Sign Embed Program, Lash Group uses Adobe Sign APIs to embed trusted, secure, and reliable electronic signatures into the patient enrollment workflow.
“For interested clients, we set up online portals to digitize document workflows, embedding Adobe Sign in an original equipment manufacturer (OEM) fashion to dramatically improve the process,” says Katie Haupt, Digital Product Manager, Lash Group. “When we can use OEM technology like Adobe Sign to streamline workflows while improving the experience for patients, prescribers, and payers that’s a big win all around.”